Konkuk University Medical Center
Seoul, 143-729, South Korea
NCT Number: NCT01819012
The purpose of this study is to determine Isoflurane's dose-dependent effect on left ventricular (LV) systolic function in cardiac surgery. The change of tissue Doppler imaging (TDI) of lateral mitral valve annular systolic velocity at three different isoflurane concentrations would be analyzed by using intraoperative transesophageal echocardiography (TEE) in cardiac surgery patients.
Looking for future studies?
Notify Me20 year–65 year
All sexes
Interventional
Not applicable
Seoul, 143-729, South Korea
Isoflurane is widely used in cardiac surgery patients due to its beneficial effects, but many studies have shown that isoflurane reduces myocardial contractility in a dose-dependent manner, and compromises left ventricular (LV) function.
Tissue Doppler imaging (TDI) of mitral annular velocity during the cardiac cycle has been introduced as a reliable method for analysis of systolic and diastolic LV long-axis function. Efficacy of systolic and diastolic TDI profiles, including systole (S'), early early relaxation (E')and atrial contraction (A') have been suggested to be useful in predicting the impact of isoflurane on LV systolic and diastolic function.
The investigators hypothesized that isoflurane, even at a clinical dosage, would affects intraoperative LV systolic function in a dose-dependent manner and thus produce significant changes int the TDI profiles of systolic mitral annular velocity (S').
So the investigators planned to study the changes in S' of lateral mitral annulus at the clinical isoflurane dosage during remifentanil based anesthesia for cardiac surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
10 min-inhalation of each concentration of isoflurane, 1.0 MAC
10 min-inhalation of each concentration of isoflurane, 1.5 MAC
10 min-inhalation of each concentration of isoflurane, 2.0 MAC
Time frame: after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC
By using pulsed Doppler with the sample volume positioned at the lateral mitral valve (MV)ring in the midesophageal 4-chamber view, S' would be determined just after the 10 min-exposure to each concentration of isoflurane, 1.0 MAC, 1.5 MAC and 2.0 MAC (T1, T2 and T3, respectively)
Time frame: after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC
By using modified Simpson technique in the midesophageal 4-chamber view, EF would be determined just after the 10 min-exposure to each concentration of isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC
Time frame: after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC
BIS would be determined just after the 10 min-exposure to each concentration of isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC
Time frame: after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC
By using pulsed Doppler with the sample volume positioned at the IMV opening in the midesophageal 4-chamber view, E' would be determined just after the 10 min-exposure to each concentration of isoflurane, 1.0 MAC, 1.5 MAC and 2.0 MAC(T1, T2 and T3, respectively)
Time frame: after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC
By using pulsed Doppler with the sample volume positioned at the tip of MV opening in the midesophageal 4-chamber view, "A" would be determined just after the 10 min-exposure to each concentration of isoflurane, 1.0 MAC, 1.5 MAC and 2.0 MAC(T1, T2 and T3, respectively)
Time frame: after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC
By using pulsed Doppler with the sample volume positioned at the lateral MV ring
Time frame: after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC
By using pulsed Doppler with the sample volume positioned at the lateral MV ring
Konkuk University Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06699056
Arrhythmias, Cardiac, Atrial Enlargement
Orange, California, United States
View Trial DetailsNCT05654272
Aortic Diseases, Arrhythmias, Cardiac
Cleveland, Ohio, United States
View Trial DetailsNCT07081711
Aortic Diseases, Arrhythmias, Cardiac
View Trial DetailsNCT06984211
Cardiovascular Diseases, Diabetes
Stockholm, Sweden
View Trial Details